- Report
In this report, the latest in a quarterly series, CBO highlights its recent publications and summarizes its work in progress.
- Cost Estimate
As ordered reported by the Senate Committee on Homeland Security and Governmental Affairs on May 15, 2024
- Cost Estimate
As ordered reported by the House Committee on Natural Resources on June 12, 2024
- Cost Estimate
As ordered reported by the House Committee on the Budget on September 25, 2024
- Cost Estimate
As ordered reported by the House Committee on the Budget on September 25, 2024
- Cost Estimate
As ordered reported by the House Committee on the Budget on September 25, 2024
- Cost Estimate
As ordered reported by the House Committee on the Budget on September 25, 2024
- Cost Estimate
As ordered reported by the House Committee on the Budget on September 25, 2024
- Cost Estimate
As ordered reported by the House Committee on the Budget on September 25, 2024
- Report
CBO estimates the budgetary effects of an illustrative policy that would authorize Medicare to cover anti-obesity medications. The policy would apply to all beneficiaries with obesity and some beneficiaries who are classified as overweight.